Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,957.67
(
1.04%
)
US TECH 100
25,090.40
(
1.60%
)
Dow Jones
48,510.71
(
0.61%
)
Brent Oil
92.69
(
-2.91%
)
Bitcoin
74,035.56
(
-0.62%
)
News Focus
News Focus
Post# of 257406
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

WorstLuck

Send PM Follow Ignore
Followers 15
Posts 1642
Boards Moderated 0
Alias Born 02/23/2010

WorstLuck

Re: None

Sunday, 10/23/2022 11:49:58 PM

Sunday, October 23, 2022 11:49:58 PM

Post# of 257406
MYOV

https://investors.myovant.com/news-releases/news-release-details/sumitovant-biopharma-sumitomo-pharma-and-myovant-sciences-enter/


Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement
October 23, 2022 at 11:30 PM EDT

Sumitovant Biopharma to Acquire all Outstanding Shares of Myovant for $27 Per Share in Cash

Combination Provides Expertise and Resources to Address Unmet Patient Needs in Women's Health and Prostate Cancer

Agreement Unanimously Recommended by Special Committee of Myovant's Independent Directors and Approved by Board
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today